Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYT006-AngQb in Mild to Moderate Essential Hypertension
NCT00701649Phase 2Completed
- Sponsor
- Cytos Biotechnology AG
- Start
- Mar 2008
- Primary completion
- Mar 2009
- Countries
- 2
01
Overview
A Phase 2 trial of CYT006-AngQb in essential hypertension, sponsored by Cytos Biotechnology AG. Started Mar 2008; status: completed.
02
Drugs
CYT006-AngQb
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00701649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00701649.